37 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
BPMC Blueprint Medicines Corporation $88.02 $3.83B Buy
Article Searches
Blueprint Medicines 2017 Q4 - Results - Earnings Call Slides https://seekingalpha.com/article/4149529-blueprint-medicines-2017-q4-results-earnings-call-slides?source=feed_sector_healthcare Feb 22, 2018 - The following slide deck was published by Blueprint Medicines in conjunction with their 2017 Q4 earnings call.
Blueprint Medicines' (BPMC) CEO Jeff Albers on Q4 2017 Results - Earnings Call Transcript https://seekingalpha.com/article/4149069-blueprint-medicines-bpmc-ceo-jeff-albers-q4-2017-results-earnings-call-transcript?source=feed_sector_healthcare Feb 21, 2018 - Blueprint Medicines. (NASDAQ:BPMC) Q4 2017 Results Earnings Conference Call February 21, 2018, 08:30 AM ET Executives Kristin Hodous - Investor Relations Jeff Albers - Chief Executive Officer Andy Bor
Blueprint Medicines reports Q4 results https://seekingalpha.com/news/3332717-blueprint-medicines-reports-q4-results?source=feed_news_all Feb 21, 2018 - Blueprint Medicines (BPMC) Q4 results: Revenues: $1.6M (-79.2%); Net Loss: ($49M); Loss Per Share: ($1.23) (-64.0%); Quick Assets: $673.4M.Financial Guidance: Blueprint Medicines expects that its exis
Biotech: The Gates Begin To Open https://seekingalpha.com/article/4140443-biotech-gates-begin-open?source=feed_sector_healthcare Jan 26, 2018 - Biotech sector starts off the year strong with multiple acquisitions and partnerships, beginning to usher in the long-awaited M&A boom.Furthermore, unlike last October, earnings season this time has o
Will Intuitive Surgical (ISRG) Disappoint in Q4 Earnings? http://www.zacks.com/stock/news/288961/will-intuitive-surgical-isrg-disappoint-in-q4-earnings?cid=CS-ZC-FT-288961 Jan 16, 2018 - Intuitive Surgical (ISRG) is expected to witness growth across da Vinci Surgical and Service segments. Instruments and accessories revenues are also expected to increase year over year.
Biotech Bonanza: Biotech Stocks To Keep Shining In 2018 https://seekingalpha.com/article/4132749-biotech-bonanza-biotech-stocks-keep-shining-2018?source=feed_tag_etf_portfolio_strategy Dec 19, 2017 - Biotechnology delivered a solid year in 2017, overcoming the poor performance in 2016.Multiple reasons for Biotechs to continue performing strongly in 2018.On a relative basis, Biotechs represent a go
Blueprint Medicines: Buy The Secondary https://seekingalpha.com/article/4132025-blueprint-medicines-buy-secondary?source=feed_sector_healthcare Dec 15, 2017 - Shares have risen well over 200% since my initial write-up on this nascent leader in targeted oncology.Results in GIST and SM have been quite impressive.After the recent secondary, the company has sig
Your Daily Pharma Scoop: Right Time To Buy Regeneron, Eli Lilly Gives Guidance, Bluebird Announces Offering https://seekingalpha.com/article/4131769-daily-pharma-scoop-right-time-buy-regeneron-eli-lilly-gives-guidance-bluebird-announces?source=feed_sector_healthcare Dec 14, 2017 - Regeneron is significantly undervalued at current levels. Eli Lilly has provided guidance for 2018. Bluebird has announced a public offering.
Blueprint Medicines (BPMC) Avapritinib In Advanced Systemic Mastocytosis - Slideshow https://seekingalpha.com/article/4131382-blueprint-medicines-bpmc-avapritinib-advanced-systemic-mastocytosis-slideshow?source=feed_sector_healthcare Dec 12, 2017 - The following slide deck was published by Blueprint Medicines in conjunction with this event.
Blueprint Medicines (BPMC) Set A New High On Phase 1 Trial Results http://www.rttnews.com/story.aspx?Id=2843737 Dec 12, 2017 - Blueprint Medicines (BPMC) announced Sunday that its Phase 1 trial of avapritinib showed strong clinical activity.

Pages: 1234

Page 1>

Related Companies

Name Exchange Price Mkt Cap
ARRY Array BioPharma Inc. NASDAQ $18.15 $3.77B
AKRX Akorn, Inc. NASDAQ $30.12 $3.77B
ACAD ACADIA Pharmaceuticals Inc. NASDAQ $31.52 $3.91B
TARO Taro Pharmaceutical Industries Ltd. NYSE $100.32 $4.02B
SRPT Sarepta Therapeutics, Inc. NASDAQ $63.91 $4.13B
Sector: Health Care > Industry: Major Pharmaceuticals
DeepLinks for Blueprint Medicines
BPMC - Google Finance https://www.google.com/finance?q=BPMC Industry related info and international coverage Summary News
BPMC - Bloomberg http://www.bloomberg.com/research/stocks/snapshot/snapshot.asp?ticker=BPMC Original news and commentary from Bloomberg Charts Financials with pensions Snapshot Earnings Transactions People Options